Related Experiment Video
Updated: Jun 25, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
Schlafens: Emerging Therapeutic Targets
Ricardo E Perez1,2, Frank Eckerdt1,2, Leonidas C Platanias1,2,3
1Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA.
Abstract:
The interferon (IFN) family of immunomodulatory cytokines has been a focus of cancer research for over 50 years with direct and indirect implications in cancer therapy due to their properties to inhibit malignant cell proliferation and modulate immune responses. Among the transcriptional targets of the IFNs is a family of genes referred to as Schlafens. The products of these genes, Schlafen proteins, exert important roles in modulating cellular proliferation, differentiation, immune responses, viral replication, and chemosensitivity of malignant cells. Studies have demonstrated that abnormal expression of various Schlafens contributes to the pathophysiology of various cancers. Schlafens are now emerging as promising biomarkers and potentially attractive targets for drug development in cancer research. Here, we highlight research suggesting the use of Schlafens as cancer biomarkers and the rationale for the development of specific drugs targeting Schlafen proteins.
Insights
Interferons (IFNs) impact cancer therapy by inhibiting cancer growth. Their target genes, Schlafens, are crucial for cell functions and are implicated in cancer, emerging as biomarkers and drug targets.
Area of Science:
- Immunology and Cancer Biology
- Cytokine Signaling and Gene Regulation
Background:
- The interferon (IFN) family of cytokines has been studied for over 50 years for its role in cancer therapy.
- IFNs inhibit malignant cell proliferation and modulate immune responses, influencing cancer progression and treatment.
- Schlafen (SLFN) genes are transcriptional targets of IFNs, and their protein products play key roles in cellular processes.
Purpose of the Study:
- To highlight research on the role of Schlafens in cancer.
- To explore the potential of Schlafens as cancer biomarkers.
- To present the rationale for developing drugs targeting Schlafen proteins in cancer therapy.
Main Methods:
- Review of existing scientific literature on interferon signaling and Schlafen gene family.
- Analysis of studies investigating the expression and function of Schlafen proteins in various cancers.
- Examination of research linking Schlafen dysregulation to cancer pathophysiology and treatment response.
Main Results:
- Schlafen proteins modulate critical cellular functions including proliferation, differentiation, immune response, viral replication, and chemosensitivity.
- Abnormal expression of specific Schlafens is associated with the development and progression of diverse cancers.
- Schlafens demonstrate potential as reliable biomarkers for cancer diagnosis and prognosis.
Conclusions:
- Schlafens are emerging as significant players in cancer biology, influencing tumor growth and immune evasion.
- The dysregulation of Schlafen expression highlights their contribution to cancer pathophysiology.
- Schlafens represent promising novel biomarkers and therapeutic targets for the development of targeted cancer drugs.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Management of Insomnia
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...

